Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Pharmaceutical policy in countries with developing healthcare systems / Zaheer-Ud-Din Babar, editor

Contributor(s): Babar, Zaheer-ud-din,, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Adis, 2017Description: 1 recurso en línea (xii, 430 páginas) : ilustraciones (algunas a color).ISBN: 3319516736; 9783319516738.Subject: Política sanitariaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Foreword; Preface; Contents; Chapter 1: Introduction; 1.1 Pharmaceutical Policy and€the€Right to€Health; 1.2 Pharmaceutical Production and€Supply; 1.3 Access to€Affordable Drugs; 1.4 Conclusion; References; Part I: Low and Lower Middle Income Countries; Chapter 2: Pharmaceutical Policy in€the€East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania; 2.1 Background; 2.1.1 Focus of€This Chapter; 2.1.2 Health System of€the€EAC (Health System and€Health Indicators); 2.2 Pharmaceutical Situation of€the€EAC; 2.3 EAC Medicines Policy, Legislative and€Regulatory Environment.
2.4 Conclusions: Summary and€Way ForwardReferences; Chapter 3: Pharmaceutical Policy in€Pakistan; 3.1 Pakistan; 3.1.1 Country Profile; 3.2 Health System of€Pakistan; 3.2.1 Health System; 3.2.2 Health Indicators; 3.3 Pharmaceutical Situation of€the€Country; 3.3.1 Pharmaceutical Industry and€Key Statistics; 3.4 Country's Regulatory Environment; 3.4.1 Medicines Regulatory Authority; 3.4.2 Quality Control; 3.4.3 Pharmacovigilance; 3.4.4 Counterfeit Medicines; 3.5 Medicines Supply System; 3.5.1 Procurement; 3.5.2 Distribution; 3.6 Medicines Financing; 3.6.1 Medicines Expenditures in€General.
3.6.2 Medicines Pricing3.6.3 Affordability; 3.6.4 Generic Medicines; 3.7 Medicines Use (Issues Impacting on€Rationale Medicines Use in€the€Country); 3.7.1 Medicines Use in€General (in Community Pharmacies, Dispensing Doctors and€General Hospital Sector); 3.7.2 Essential Medicine List, Selection of€Essential Medicines and€Standard Treatment Guidelines; 3.7.3 Prescribing Behaviour in€General (Factors Affecting Prescribing Behaviour); 3.7.4 Medicines' Promotional Practices; 3.7.5 The Role of€Pharmacist in€Community and€Hospital Environments.
3.7.6 Medicines Use Research (Including Drug Utilization Evaluation Research)3.8 Summary and€Future Direction; References; Chapter 4: Pharmaceutical Policy in€the€Philippines; 4.1 The Philippines Health System; 4.1.1 Health System of€Philippines; 4.1.2 Health Indicators; 4.2 The Philippines Pharmaceutical Sector; 4.3 Pharmaceutical Regulation in€the€Philippines; 4.3.1 Quality Control; 4.3.2 Pharmacovigilance; 4.3.3 Substandard and€Counterfeit Medicines; 4.4 Medicines Supply System in€the€Philippines; 4.4.1 The Medicines Supply System; 4.5 Medicines Financing; 4.5.1 Medicine Pricing.
4.5.2 Price Monitoring4.5.3 Medicines Access; 4.5.4 Medicines Access Programs of€the€DOH; 4.5.5 Industry Patient Assistance Programmes; 4.5.6 Generic Medicines; 4.6 Medicines Use; 4.6.1 Medicines Use in€General; 4.6.2 Essential Medicines and€Standard Treatment Guidelines; 4.6.3 Pharmacoeconomics; 4.6.4 Prescribing Behaviour; 4.6.5 Medicines Promotional Practices; 4.6.6 Role of€Pharmacist; 4.6.7 Pharmaceutical Care Interventions and€Assessment of€Community Pharmacy Practice; 4.6.8 Medicines Use Research; 4.7 Conclusions and€Way Forward; References; Chapter 5: Pharmaceutical Policy in€Vietnam.
Abstract: A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RA401 .A1 2017 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20023281
Total holds: 0

SpringerLink

Foreword; Preface; Contents; Chapter 1: Introduction; 1.1 Pharmaceutical Policy and€the€Right to€Health; 1.2 Pharmaceutical Production and€Supply; 1.3 Access to€Affordable Drugs; 1.4 Conclusion; References; Part I: Low and Lower Middle Income Countries; Chapter 2: Pharmaceutical Policy in€the€East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania; 2.1 Background; 2.1.1 Focus of€This Chapter; 2.1.2 Health System of€the€EAC (Health System and€Health Indicators); 2.2 Pharmaceutical Situation of€the€EAC; 2.3 EAC Medicines Policy, Legislative and€Regulatory Environment.

2.4 Conclusions: Summary and€Way ForwardReferences; Chapter 3: Pharmaceutical Policy in€Pakistan; 3.1 Pakistan; 3.1.1 Country Profile; 3.2 Health System of€Pakistan; 3.2.1 Health System; 3.2.2 Health Indicators; 3.3 Pharmaceutical Situation of€the€Country; 3.3.1 Pharmaceutical Industry and€Key Statistics; 3.4 Country's Regulatory Environment; 3.4.1 Medicines Regulatory Authority; 3.4.2 Quality Control; 3.4.3 Pharmacovigilance; 3.4.4 Counterfeit Medicines; 3.5 Medicines Supply System; 3.5.1 Procurement; 3.5.2 Distribution; 3.6 Medicines Financing; 3.6.1 Medicines Expenditures in€General.

3.6.2 Medicines Pricing3.6.3 Affordability; 3.6.4 Generic Medicines; 3.7 Medicines Use (Issues Impacting on€Rationale Medicines Use in€the€Country); 3.7.1 Medicines Use in€General (in Community Pharmacies, Dispensing Doctors and€General Hospital Sector); 3.7.2 Essential Medicine List, Selection of€Essential Medicines and€Standard Treatment Guidelines; 3.7.3 Prescribing Behaviour in€General (Factors Affecting Prescribing Behaviour); 3.7.4 Medicines' Promotional Practices; 3.7.5 The Role of€Pharmacist in€Community and€Hospital Environments.

3.7.6 Medicines Use Research (Including Drug Utilization Evaluation Research)3.8 Summary and€Future Direction; References; Chapter 4: Pharmaceutical Policy in€the€Philippines; 4.1 The Philippines Health System; 4.1.1 Health System of€Philippines; 4.1.2 Health Indicators; 4.2 The Philippines Pharmaceutical Sector; 4.3 Pharmaceutical Regulation in€the€Philippines; 4.3.1 Quality Control; 4.3.2 Pharmacovigilance; 4.3.3 Substandard and€Counterfeit Medicines; 4.4 Medicines Supply System in€the€Philippines; 4.4.1 The Medicines Supply System; 4.5 Medicines Financing; 4.5.1 Medicine Pricing.

4.5.2 Price Monitoring4.5.3 Medicines Access; 4.5.4 Medicines Access Programs of€the€DOH; 4.5.5 Industry Patient Assistance Programmes; 4.5.6 Generic Medicines; 4.6 Medicines Use; 4.6.1 Medicines Use in€General; 4.6.2 Essential Medicines and€Standard Treatment Guidelines; 4.6.3 Pharmacoeconomics; 4.6.4 Prescribing Behaviour; 4.6.5 Medicines Promotional Practices; 4.6.6 Role of€Pharmacist; 4.6.7 Pharmaceutical Care Interventions and€Assessment of€Community Pharmacy Practice; 4.6.8 Medicines Use Research; 4.7 Conclusions and€Way Forward; References; Chapter 5: Pharmaceutical Policy in€Vietnam.

A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.

Online resource; title from PDF title page (SpringerLink, viewed April 12, 2017).

There are no comments on this title.

to post a comment.
Share